Carl provides a 360-degree global perspective of the healthcare and life sciences ecosystem, integrating analysis, decision-making, strategy, architecture, implementation, measurement, adjustment, focusing on asset maximization, lifecycle management, resource allocation, priority challenges/opportunities, to marry history, currency, predictive vision. Carl has studied the psychological and sociological aspects of enhancing the person-patient journey for over 40 years.

General management, consulting, strategic planning, marketing/sales, go-to-market, business development, insurance, payers, public health, provider networks, distribution, regulatory, patient journey, multiculturalism, associations, competitive intelligence, market research.

Biopharmaceutical, devices, diagnostics, vaccines, veterinary, dental, supplements, brands, biosimilars, OTC, orphans, alternative forms, Rx-OTC, genericization, informatics, infusion, alternative sites, API.

Arthritis/Pain, Cardiometabolic, CNS/Psychiatric, Cognitive Deficit, Movement Disorders, Dermatology, Endocrine/Diabetes, Epilepsy, Gastroenterology, Hepatitis, Nephrology, Ophthalmology, Oncology/Hematology, Infectious Diseases, Respiratory, Sleep, Urology, Wound Care.

Aurora WDC, Proactive Worldwide, Verix, MTS/QualityHealth, AmericasDoctor/Essential Group, USP, GD Searle, Boots Pharmaceuticals, Flint Laboratories/Baxter, Health Systems/Dimensional Marketing, Derenfeld Associates Consulting.

Master's in Business Administration from Northwestern University (J.L. Kellogg School of Management), Masters of Social Work from Yeshiva University (Wurzweiler School), BA, SUNY Stony Brook